Skullcandy Inc (NASDAQ:SKUL): After the firm analyzed headphone promotions during Black Friday weekend, DA Davidson is convinced that Skullcandy continues to be a top headphone brand, and consumer interest in the category continues to be strong. The firm keeps its Buy rating and a $19 price target on the stock.
Interpublic Group of Companies, Inc. (NYSE:IPG) has been added to Wedbush’s Best Ideas List due to the expectation that the company will hit Street margin targets reaching 10.1 percent during 2012. Also, Q4 revenue outlook is to be at or above expectations. Shares keep an Outperform rating and a $12.75 price target.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
JPMorgan Chase & Co. (NYSE:JPM): According to ISI Group, JPMorgan’s valuation continues to be attractive and estimates are too low. The firm predicts that JPMorgan will increase its dividend to $1.40 in March 2013, and it will buy back between $8 billion to $10 billion of stock next year.
Nektar Therapeutics (NASDAQ:NKTR) migraine treatment, Levadex, received an April 2013 action date by the FDA, and Roth Capital believes that the company’s assets are worth far more than the amount that is reflected by the company’s stock. The firm doesn’t believe that Nektar’s Naloxegol in opioid-related constipation will face the same issues with the FDA as a possible competing product made by Salix (NASDAQ:SLXP). Roth keeps its Buy rating and a $12 price target on the stock.
Don’t Miss: Apple Becomes Bigger Part of Thanksgiving Feast.